Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2010-04-02

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2010-03-19

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2010-03-19

View Filing

NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form Type: NT 10-Q

Filing Date: 2010-03-18

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2010-03-09

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2010-03-05

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2010-02-25

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2010-02-19

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2010-02-16

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2010-02-16

View Filing